Low catechol-O-methyltransferase and 2-methoxyestradiol in preeclampsia: more than a unifying hypothesis.
Dragun
Duska
D
Department of Nephrology and Intensive Care Medicine, Charité University Hospital, Berlin, Germany. duska.dragun@charite.de
Haase-Fielitz
Anja
A
D000077584:2-Methoxyestradiol; D000818:Animals; D002394:Catechol O-Methyltransferase / Q000172:deficiency* / Q000502:physiology; D004730:Endothelium, Vascular / Q000503:physiopathology; D004958:Estradiol / Q000031:analogs & derivatives* / Q000096:biosynthesis / Q000502:physiology; D005260:Female; D006801:Humans; D051379:Mice; D008954:Models, Biological; D009389:Neovascularization, Pathologic; D011225:Pre-Eclampsia / Q000209:etiology* / Q000503:physiopathology; D011247:Pregnancy; D015398:Signal Transduction; D042461:Vascular Endothelial Growth Factor A / Q000502:physiology; D040281:Vascular Endothelial Growth Factor Receptor-1 / Q000502:physiology
D042461:Vascular Endothelial Growth Factor A; D004958:Estradiol; D000077584:2-Methoxyestradiol; D002394:Catechol O-Methyltransferase; D040281:Vascular Endothelial Growth Factor Receptor-1